Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.72 |
| ▸ | LMNA | P02545 | 2/20 | 0.69 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31546430 | 1.00 | MEN1 (0.72) | MEN1KMT2ALMNAMAPTPOLB | |
| SCHEMBL31546452 | 0.84 | LMNA (0.81) | MEN1KMT2ALMNAMAPTPOLB | |
| SCHEMBL31546443 | 0.83 | MEN1 (0.84) | MEN1KMT2ALMNAMAPTPOLB | |
| SCHEMBL31546459 | 0.82 | MEN1 (0.86) | MEN1KMT2ALMNAMAPTPOLB | |
| SCHEMBL31546334 | 0.82 | MEN1 (0.71) | MEN1KMT2ALMNAMAPTPOLB | |
| SCHEMBL30584801 | 0.80 | LMNA (0.75) | MEN1KMT2ALMNAMAPTPOLB | |
| SCHEMBL31546330 | 0.80 | MEN1 (0.72) | MEN1KMT2ALMNAMAPTPOLB | |
| SCHEMBL25435527 | 0.77 | MEN1 (0.68) | MEN1KMT2ALMNAMAPTPOLB | |
| SCHEMBL31546446 | 0.77 | MAPT (0.86) | MEN1KMT2ALMNAMAPTPOLB | |
| SCHEMBL31546455 | 0.77 | SMN1; SMN2 (0.77) | MEN1KMT2ALMNAMAPTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023177700-A2 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC. (US) | 2023-09-21 | — | — | WO | disclosed |